<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38054899</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1591-951X</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Pathologica</Title><ISOAbbreviation>Pathologica</ISOAbbreviation></Journal><ArticleTitle>COVID-19. Biology, pathophysiology, and immunology: a pathologist view.</ArticleTitle><Pagination><StartPage>248</StartPage><EndPage>256</EndPage><MedlinePgn>248-256</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.32074/1591-951X-954</ELocationID><Abstract><AbstractText>Even if the SARS-CoV-2 pandemic has been declared over, several risks and clinical problems remain to be faced, including long-COVID sequelae and possible outbreaks of pathogenic variants. Intense research on COVID-19 has provided in these few years a striking amount of data covering different fields and disciplines, which can help to provide a knowledge shield against new potential infective spreads, and may also potentially be applied to other fields of medicine, including oncology and neurology. Nevertheless, areas of uncertainty still remain regarding the pathogenic mechanisms that subtend the multifaceted manifestations of the disease. To better clarify the pathogenesis of the disease, a systematic multidisciplinary evaluation of the many mechanisms involved in COVID-19 is mandatory, including clinical, physiological, radiological, immunological and pathological studies. In COVID-19 syndrome the pathological studies have been mainly performed on autopsy cases, and only a few studies are available on biopsies. Nevertheless, these studies have provided relevant information that can substantially contribute to decipher the complex scenario characterizing the different forms of COVID-19 and long-COVID-19. In this review the data provided by pathological investigations are recapitulated and discussed, in the light of different hypothesis and data provided by clinical, physiological and immunological data.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Societ&#xe0; Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chilosi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Pederzoli Hospital, Peschiera del Garda, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doglioni</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pathology, San Raffaele Scientific Institute. Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravaglia</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Diseases of the Thorax, Ospedale GB Morgagni, Forl&#xec;, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piciucchi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Diseases of the Thorax, Ospedale GB Morgagni, Forl&#xec;, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dubini</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology, Ospedale GB Morgagni, Forl&#xec;, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanizzi</LastName><ForeName>Lavinia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology, Pederzoli Hospital, Peschiera del Garda, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poletti</LastName><ForeName>Venerino</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Diseases of the Thorax, Ospedale GB Morgagni, Forl&#xec;, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Ospedale GB Morgagni, Forl&#xec;, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Pathologica</MedlineTA><NlmUniqueID>0401123</NlmUniqueID><ISSNLinking>0031-2983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072142" MajorTopicYN="N">Pathologists</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001695" MajorTopicYN="N">Biology</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">lung biopsy</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">post-COVID</Keyword></KeywordList><CoiStatement>The authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38054899</ArticleId><ArticleId IdType="pmc">PMC10699332</ArticleId><ArticleId IdType="doi">10.32074/1591-951X-954</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum DC, June CH. Cytokine Storm. N Engl J Med 2020; 383: 2255-2573. https://doi.org/10.1056/NEJMra2026131 10.1056/NEJMra2026131</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Fu B, Zheng X, et al. . Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev 2020; 7: 998-1002. https://doi.org/10.1093/nsr/nwaa041 10.1093/nsr/nwaa041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa041</ArticleId><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zhuang MW, Deng J, et al. . SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways. J Med Virol 2021; 93: 5376-5389. https://doi.org/10.1002/jmv.27050 10.1002/jmv.27050</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zheng Y, Deng J, et al. . SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy. J Med Virol 2022; 94: 5174-5188. https://doi.org/10.1002/jmv.27965 10.1002/jmv.27965</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27965</ArticleId><ArticleId IdType="pmc">PMC9350412</ArticleId><ArticleId IdType="pubmed">35765167</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Zheng Y, Zheng SN, et al. . SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways. J Med Virol 2023; 95: e28561. https://doi.org/10.1002/jmv.28680 10.1002/jmv.28680</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28680</ArticleId><ArticleId IdType="pubmed">36755358</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai S, Zhang C, Zhuang Z, et al. . Phase-separated nucleocapsid protein of SARS-CoV-2 suppresses cGAS-DNA recognition by disrupting cGAS-G3BP1 complex. Signal Transduct Target Ther 2023; 8: 170. https://doi.org/10.1038/s41392-023-01420-9 10.1038/s41392-023-01420-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01420-9</ArticleId><ArticleId IdType="pmc">PMC10131525</ArticleId><ArticleId IdType="pubmed">37100798</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu C, Li X, Li P. The mechanism of double-stranded DNA sensing through the cGAS-STING pathway. Cytokine Growth Factor Rev 2014; 25: 641-648. https://doi.org/10.1016/j.cytogfr.2014.06.006 10.1016/j.cytogfr.2014.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.06.006</ArticleId><ArticleId IdType="pmc">PMC4254336</ArticleId><ArticleId IdType="pubmed">25007740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng PH, Yin WJ. The cGAS/STING signaling pathway: a cross-talk of infection, senescence and tumors. Cell Cycle 2023; 22: 38-56. https://doi.org/10.1080/15384101.2022.2109899 10.1080/15384101.2022.2109899</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2022.2109899</ArticleId><ArticleId IdType="pmc">PMC9769453</ArticleId><ArticleId IdType="pubmed">35946607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornung V, Hartmann R, Ablasser A, et al. . OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids. Nat Rev Immunol 2014; 14: 521-528. https://doi.org/10.1038/nri3719 10.1038/nri3719</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3719</ArticleId><ArticleId IdType="pmc">PMC7097587</ArticleId><ArticleId IdType="pubmed">25033909</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Reyes HM, Yang JF, et al. . Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection. J Virol 2021; 95: e00490-21. https://doi.org/10.1128/JVI.00490-21 10.1128/JVI.00490-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00490-21</ArticleId><ArticleId IdType="pmc">PMC8316077</ArticleId><ArticleId IdType="pubmed">33789998</ArticleId></ArticleIdList></Reference><Reference><Citation>Neufeldt CJ, Cerikan B, Cortese M, et al. . SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-&#x3ba;B. Commun Biol 2022; 5: 45. https://doi.org/10.1038/s42003-021-02983-5 10.1038/s42003-021-02983-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02983-5</ArticleId><ArticleId IdType="pmc">PMC8755718</ArticleId><ArticleId IdType="pubmed">35022513</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domizio JD, Gulen MF, Saidoune F, et al. . The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 2022; 603: 145-151. https://doi.org/10.1038/s41586-022-04421-w 10.1038/s41586-022-04421-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04421-w</ArticleId><ArticleId IdType="pmc">PMC8891013</ArticleId><ArticleId IdType="pubmed">35045565</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreakos E. STINGing type I IFN-mediated immunopathology in COVID-19. Nat Immunol 2022; 23: 478-480. https://doi.org/10.1038/s41590-022-01174-6 10.1038/s41590-022-01174-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01174-6</ArticleId><ArticleId IdType="pubmed">35301509</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Li Y, Shen X, et al. . Dampened STING-Dependent Interferon Activation in Bats. Cell Host Microbe 2018; 23: 297-301.e4. https://doi.org/10.1016/j.chom.2018.01.006 10.1016/j.chom.2018.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2018.01.006</ArticleId><ArticleId IdType="pmc">PMC7104992</ArticleId><ArticleId IdType="pubmed">29478775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa Ribero M, Jouvenet N, Dreux M, et al. . Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog 2020; 16: e1008737. https://doi.org/10.1371/journal.ppat.1008737 10.1371/journal.ppat.1008737</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008737</ArticleId><ArticleId IdType="pmc">PMC7390284</ArticleId><ArticleId IdType="pubmed">32726355</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H, Cao Z, Xie X, et al. . Evasion of Type I Interferon by SARS-CoV-2. Cell Rep 2020; 33: 108234. https://doi.org/10.1016/j.celrep.2020.108234 10.1016/j.celrep.2020.108234</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108234</ArticleId><ArticleId IdType="pmc">PMC7501843</ArticleId><ArticleId IdType="pubmed">32979938</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen CK, Lam JY, Wong WM, et al. . SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists. Emerg Microbes Infect 2020; 9: 1418-1428. https://doi.org/10.1080/22221751.2020.1780953 10.1080/22221751.2020.1780953</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1780953</ArticleId><ArticleId IdType="pmc">PMC7473193</ArticleId><ArticleId IdType="pubmed">32529952</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Su W, Tang H, et al. . Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov 2020; 6: 31. https://doi.org/10.1038/s41421-020-0168-9 10.1038/s41421-020-0168-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0168-9</ArticleId><ArticleId IdType="pmc">PMC7197635</ArticleId><ArticleId IdType="pubmed">32377375</ArticleId></ArticleIdList></Reference><Reference><Citation>Trombetta AC, Farias GB, Gomes AMC, et al. . Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype. Front Immunol 2021; 12: 691725. https://doi.org/10.3389/fimmu.2021.691725 10.3389/fimmu.2021.691725</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.691725</ArticleId><ArticleId IdType="pmc">PMC8265310</ArticleId><ArticleId IdType="pubmed">34248984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Belkacem I, Cartagena Garc&#xed;a C, Millet-Wallisky E, et al. . SARS-CoV-2 spike protein induces a differential monocyte activation that may contribute to age bias in COVID-19 severity. Sci Rep 2022; 12: 20824. https://doi.org/10.1038/s41598-022-25259-2 10.1038/s41598-022-25259-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25259-2</ArticleId><ArticleId IdType="pmc">PMC9716544</ArticleId><ArticleId IdType="pubmed">36460710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bost P, De Sanctis F, Can&#xe8; S, et al. . Deciphering the state of immune silence in fatal COVID-19 patients. Nat Commun 2021; 12: 1428. https://doi.org/10.1038/s41467-021-21702-6 10.1038/s41467-021-21702-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21702-6</ArticleId><ArticleId IdType="pmc">PMC7935849</ArticleId><ArticleId IdType="pubmed">33674591</ArticleId></ArticleIdList></Reference><Reference><Citation>Falck-Jones S, &#xd6;sterberg B, Smed-S&#xf6;rensen A. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity. J Intern Med 2023; 293: 130-143. https://doi.org/10.1111/joim.13559 10.1111/joim.13559</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13559</ArticleId><ArticleId IdType="pmc">PMC9538918</ArticleId><ArticleId IdType="pubmed">35996885</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan YM, Zhang YL, Luo H, et al. . Crosstalk between RNA viruses and DNA sensors: Role of the cGAS-STING signalling pathway. Rev Med Virol 2022; 32: e2343. https://doi.org/10.1002/rmv.2343 10.1002/rmv.2343</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2343</ArticleId><ArticleId IdType="pubmed">35253955</ArticleId></ArticleIdList></Reference><Reference><Citation>Amurri L, Horvat B, Iampietro M. Interplay between RNA viruses and cGAS/STING axis in innate immunity. Front Cell Infect Microbiol 2023; 13: 1172739. https://doi.org/10.3389/fcimb.2023.1172739 10.3389/fcimb.2023.1172739</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1172739</ArticleId><ArticleId IdType="pmc">PMC10106766</ArticleId><ArticleId IdType="pubmed">37077526</ArticleId></ArticleIdList></Reference><Reference><Citation>Augusto DG, Murdolo LD, Chatzileontiadou DSM, et al. . A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. Nature 2023; 620: 128-136. https://doi.org/10.1038/s41586-023-06331-x 10.1038/s41586-023-06331-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06331-x</ArticleId><ArticleId IdType="pmc">PMC10396966</ArticleId><ArticleId IdType="pubmed">37468623</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai J, Cervantes C, Liu J, et al. . DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mtDNA release-activated cGAS-cGAMP-STING pathway. Proc Natl Acad Sci U S A 2017; 114: 12196-12201. https://doi.org/10.1073/pnas.1708744114 10.1073/pnas.1708744114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1708744114</ArticleId><ArticleId IdType="pmc">PMC5699051</ArticleId><ArticleId IdType="pubmed">29087318</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz CRR, Maurmann RM, Guma FTCR, et al. . cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging. Front Immunol 2023; 14: 1132653. https://doi.org/10.3389/fimmu.2023.1132653 10.3389/fimmu.2023.1132653</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1132653</ArticleId><ArticleId IdType="pmc">PMC10011111</ArticleId><ArticleId IdType="pubmed">36926349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W, Feng D, Xiong X, et al. . The Role of cGAS-STING in Age-Related Diseases from Mechanisms to Therapies. Aging Dis 2023; 14: 1145-1165. https://doi.org/10.14336/AD.2023.0117 10.14336/AD.2023.0117</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2023.0117</ArticleId><ArticleId IdType="pmc">PMC10389832</ArticleId><ArticleId IdType="pubmed">37163421</ArticleId></ArticleIdList></Reference><Reference><Citation>Elzinga SE, Henn R, Murdock BJ, et al. . cGAS/STING and innate brain inflammation following acute high-fat feeding. Front Immunol 2022; 13: 1012594. https://doi.org/10.3389/fimmu.2022.1012594 10.3389/fimmu.2022.1012594</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1012594</ArticleId><ArticleId IdType="pmc">PMC9556783</ArticleId><ArticleId IdType="pubmed">36248795</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H, Zhao R, He Q, et al. . cGAS-STING mediates cytoplasmic mitochondrial-DNA-induced inflammatory signal transduction during accelerated senescence of pancreatic &#x3b2;-cells induced by metabolic stress. FASEB J 2022; 36: e22266. https://doi.org/10.1096/fj.202101988R 10.1096/fj.202101988R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202101988R</ArticleId><ArticleId IdType="pubmed">35357035</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang N, Cui C, Guo X, et al. . cGAS-STING activation contributes to podocyte injury in diabetic kidney disease. iScience 2022; 25: 105145. https://doi.org/10.1016/j.isci.2022.105145 10.1016/j.isci.2022.105145</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105145</ArticleId><ArticleId IdType="pmc">PMC9513272</ArticleId><ArticleId IdType="pubmed">36176590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 2020; 369: 718-724. https://doi.org/10.1126/science.abc6027 10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, Liu Z, et al. . Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020; 370: eabd4570. https://doi.org/10.1126/science.abd4570 10.1126/science.abd4570</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Bastard P, COVID Human Genetic Effort et al. . Human genetic and immunological determinants of critical COVID-19 pneumonia. Nature 2022; 603:587-598. https://doi.org/10.1038/s41586-022-04447-0 10.1038/s41586-022-04447-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04447-0</ArticleId><ArticleId IdType="pmc">PMC8957595</ArticleId><ArticleId IdType="pubmed">35090163</ArticleId></ArticleIdList></Reference><Reference><Citation>Matuozzo D, Talouarn E, Marchal A, et al. . Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med 2023; 15: 22. https://doi.org/10.1186/s13073-023-01173-8 10.1186/s13073-023-01173-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-023-01173-8</ArticleId><ArticleId IdType="pmc">PMC10074346</ArticleId><ArticleId IdType="pubmed">37020259</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova JL, Anderson MS. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs. J Clin Invest 2023; 133: e166283. https://doi.org/10.1172/JCI166283 10.1172/JCI166283</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI166283</ArticleId><ArticleId IdType="pmc">PMC9888384</ArticleId><ArticleId IdType="pubmed">36719370</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, et al. . Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 2020; 370: eabd4585. https://doi.org/10.1126/science.abd4585 10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Wang W. Auto-antibodies against type I IFNs are associated with severe COVID-19 pneumonia. Signal Transduct Target Ther 2021; 6: 96. https://doi.org/10.1038/s41392-021-00514-6 10.1038/s41392-021-00514-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00514-6</ArticleId><ArticleId IdType="pmc">PMC7908001</ArticleId><ArticleId IdType="pubmed">33637681</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippot Q, Fekkar A, Gervais A, et al. . J Clin Immunol 2023; 43: 1093-1103. https://doi.org/10.1007/s10875-023-01512-9 10.1007/s10875-023-01512-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-023-01512-9</ArticleId><ArticleId IdType="pmc">PMC10199445</ArticleId><ArticleId IdType="pubmed">37209324</ArticleId></ArticleIdList></Reference><Reference><Citation>Simula ER, Manca MA, Noli M, et al. . Increased Presence of Antibodies against Type I Interferons and Human Endogenous Retrovirus W in Intensive Care Unit COVID-19 Patients. Microbiol Spectr 2022; 10: e0128022. https://doi.org/10.1128/spectrum.01280-22 10.1128/spectrum.01280-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01280-22</ArticleId><ArticleId IdType="pmc">PMC9430400</ArticleId><ArticleId IdType="pubmed">35852349</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuyama M, Kong Y, Song E, et al. . ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses. Proc Natl Acad Sci U S A 2018; 115: 12565-12572. https://doi.org/10.1073/pnas.1814589115 10.1073/pnas.1814589115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1814589115</ArticleId><ArticleId IdType="pmc">PMC6294949</ArticleId><ArticleId IdType="pubmed">30455304</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A. Role of endogenous retroviruses in autoimmune diseases. Rheum Dis Clin North Am 2003; 29: 123-43, vii. https://doi.org/10.1016/s0889-857x(02)00098-4 10.1016/s0889-857x(02)00098-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0889-857x(02)00098-4</ArticleId><ArticleId IdType="pubmed">12635504</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A, Nagy G, Koncz A, et al. . Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity 2008; 41: 287-97. https://doi.org/10.1080/08916930802024764 10.1080/08916930802024764</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930802024764</ArticleId><ArticleId IdType="pmc">PMC5294745</ArticleId><ArticleId IdType="pubmed">18432409</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkman HE, Stetson DB. The enemy within: endogenous retroelements and autoimmune disease. Nat Immunol 2014; 15: 415-422. https://doi.org/10.1038/ni.2872 10.1038/ni.2872</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2872</ArticleId><ArticleId IdType="pmc">PMC4131434</ArticleId><ArticleId IdType="pubmed">24747712</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein RA, DePaola RV. Human endogenous retroviruses: our genomic fossils and companions. Physiol Genomics 2023; 55: 249-258. https://doi.org/10.1152/physiolgenomics.00171.2022 10.1152/physiolgenomics.00171.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00171.2022</ArticleId><ArticleId IdType="pubmed">37154499</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolei A. The aliens inside us: HERV-W endogenous retroviruses and multiple sclerosis. Mult Scler 2018; 24: 42-47. https://doi.org/10.1177/1352458517737370 10.1177/1352458517737370</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458517737370</ArticleId><ArticleId IdType="pubmed">29307292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruchot J, Herrero F, Weber-Stadlbauer U, et al. . Interplay between activation of endogenous retroviruses and inflammation as common pathogenic mechanism in neurological and psychiatric disorders. Brain Behav Immun 2023; 107: 242-252. https://doi.org/10.1016/j.bbi.2022.10.007 10.1016/j.bbi.2022.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.10.007</ArticleId><ArticleId IdType="pubmed">36270439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartung HP, Derfuss T, Cree BA, et al. . Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study. Mult Scler 2022; 28: 429-440. https://doi.org/10.1177/13524585211024997 10.1177/13524585211024997</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13524585211024997</ArticleId><ArticleId IdType="pubmed">34240656</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng KW, Boumelha J, Enfield KSS, et al. . Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature 2023; 616: 563-573. https://doi.org/10.1038/s41586-023-05771-9 10.1038/s41586-023-05771-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05771-9</ArticleId><ArticleId IdType="pmc">PMC10115647</ArticleId><ArticleId IdType="pubmed">37046094</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrieri E, Minutolo A, Petrone V, et al. . Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine 2021; 66: 103341. https://doi.org/10.1016/j.ebiom.2021.103341 10.1016/j.ebiom.2021.103341</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103341</ArticleId><ArticleId IdType="pmc">PMC8082064</ArticleId><ArticleId IdType="pubmed">33867312</ArticleId></ArticleIdList></Reference><Reference><Citation>Temerozo JR, Fintelman-Rodrigues N, Dos Santos MC, et al. . Human endogenous retrovirus K in the respiratory tract is associated with COVID-19 physiopathology. Microbiome 2022; 10: 65. https://doi.org/10.1186/s40168-022-01260-9 10.1186/s40168-022-01260-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-022-01260-9</ArticleId><ArticleId IdType="pmc">PMC9024070</ArticleId><ArticleId IdType="pubmed">35459226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gim&#xe9;nez-Orenga K, Pierquin J, Brunel J, et al. . HERV-W ENV antigenemia and correlation of increased anti-SARS-CoV-2 immunoglobulin levels with post-COVID-19 symptoms. Front Immunol 2022; 13: 1020064. https://doi.org/10.3389/fimmu.2022.1020064 10.3389/fimmu.2022.1020064</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1020064</ArticleId><ArticleId IdType="pmc">PMC9647063</ArticleId><ArticleId IdType="pubmed">36389746</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrone V, Fanelli M, Giudice M, et al. . Expression profile of HERVs and inflammatory mediators detected in nasal mucosa as a predictive biomarker of COVID-19 severity. Front Microbiol 2023; 14: 1155624. https://doi.org/10.3389/fmicb.2023.1155624 10.3389/fmicb.2023.1155624</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1155624</ArticleId><ArticleId IdType="pmc">PMC10239953</ArticleId><ArticleId IdType="pubmed">37283924</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N, Erb&#xec; MC, Scognamiglio S, et al. . Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages. Microbiol Spectr 2023; 11: e0251622. https://doi.org/10.1128/spectrum.02516-22 10.1128/spectrum.02516-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.02516-22</ArticleId><ArticleId IdType="pmc">PMC9927238</ArticleId><ArticleId IdType="pubmed">36602345</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N, Tramontano E. Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology. Viruses 2017; 9: 162. https://doi.org/10.3390/v9070162 10.3390/v9070162</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9070162</ArticleId><ArticleId IdType="pmc">PMC5537654</ArticleId><ArticleId IdType="pubmed">28653997</ArticleId></ArticleIdList></Reference><Reference><Citation>Charvet B, Brunel J, Pierquin J, et al. . SARS-CoV-2 awakens ancient retroviral genes and the expression of proinflammatory HERV-W envelope protein in COVID-19 patients. iScience 2023; 26: 106604. https://doi.org/10.1016/j.isci.2023.106604 10.1016/j.isci.2023.106604</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2023.106604</ArticleId><ArticleId IdType="pmc">PMC10079620</ArticleId><ArticleId IdType="pubmed">37091988</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandi N, Tramontano E. Human Endogenous Retroviruses Are Ancient Acquired Elements Still Shaping Innate Immune Responses. Front Immunol 2018; 9: 2039. https://doi.org/10.3389/fimmu.2018.02039 10.3389/fimmu.2018.02039</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02039</ArticleId><ArticleId IdType="pmc">PMC6139349</ArticleId><ArticleId IdType="pubmed">30250470</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wu X, Li W, et al. . HERV-W ENV Induces Innate Immune Activation and Neuronal Apoptosis via linc01930/cGAS Axis in Recent-Onset Schizophrenia. Int J Mol Sci 2023; 24: 3000. https://doi.org/10.3390/ijms24033000 10.3390/ijms24033000</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24033000</ArticleId><ArticleId IdType="pmc">PMC9917391</ArticleId><ArticleId IdType="pubmed">36769337</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankowski R, Strohl JJ, Huerta TS, et al. . Endogenous retroviruses are associated with hippocampus-based memory impairment. Proc Natl Acad Sci U S A 2019; 116: 25982-25990. https://doi.org/10.1073/pnas.1822164116 10.1073/pnas.1822164116</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1822164116</ArticleId><ArticleId IdType="pmc">PMC6925997</ArticleId><ArticleId IdType="pubmed">31792184</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao H, Yan J, Huang J, et al. . Activation of endogenous retrovirus triggers microglial immuno-inflammation and contributes to negative emotional behaviors in mice with chronic stress. J Neuroinflammation 2023; 20: 37. https://doi.org/10.1186/s12974-023-02724-x 10.1186/s12974-023-02724-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-023-02724-x</ArticleId><ArticleId IdType="pmc">PMC9933381</ArticleId><ArticleId IdType="pubmed">36793064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurst TP, Magiorkinis G. Epigenetic Control of Human Endogenous Retrovirus Expression: Focus on Regulation of Long-Terminal Repeats (LTRs). Viruses 2017; 9: 130. https://doi.org/10.3390/v9060130 10.3390/v9060130</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9060130</ArticleId><ArticleId IdType="pmc">PMC5490807</ArticleId><ArticleId IdType="pubmed">28561791</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardelli M. The epigenetic alterations of endogenous retroelements in aging. Mech Ageing Dev 2018; 174: 30-46. https://doi.org/10.1016/j.mad.2018.02.002 10.1016/j.mad.2018.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2018.02.002</ArticleId><ArticleId IdType="pubmed">29458070</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio E, Xodo LE. Endogenous Retroviruses (ERVs): Does RLR (RIG-I-Like Receptors)-MAVS Pathway Directly Control Senescence and Aging as a Consequence of ERV De-Repression? Front Immunol 2022; 13: 917998. https://doi.org/10.3389/fimmu.2022.917998 10.3389/fimmu.2022.917998</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.917998</ArticleId><ArticleId IdType="pmc">PMC9218063</ArticleId><ArticleId IdType="pubmed">35757716</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Liu Z, Wu Z, et al. . Resurrection of endogenous retroviruses during aging reinforces senescence. Cell 2023; 186: 287-304.e26. https://doi.org/10.1016/j.cell.2022.12.017 10.1016/j.cell.2022.12.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.12.017</ArticleId><ArticleId IdType="pubmed">36610399</ArticleId></ArticleIdList></Reference><Reference><Citation>Polak SB, Van Gool IC, Cohen D, et al. . A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol 2020; 33: 2128-2138. https://doi.org/10.1038/s41379-020-0603-3 10.1038/s41379-020-0603-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-0603-3</ArticleId><ArticleId IdType="pmc">PMC7306927</ArticleId><ArticleId IdType="pubmed">32572155</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty SK, Satapathy A, Naidu MM, et al. . Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) - anatomic pathology perspective on current knowledge. Diagn Pathol 2020; 15: 103. DOI 10.1186/s13000-020-01017-8 10.1186/s13000-020-01017-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13000-020-01017-8</ArticleId><ArticleId IdType="pmc">PMC7427697</ArticleId><ArticleId IdType="pubmed">32799894</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Shi L, Wang Y, et al. . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X 10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsana L, Sonzogni A, Nasr A, et al. . Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020; 20: 1135-1140. https://doi.org/10.1016/S1473-3099(20)30434-5 10.1016/S1473-3099(20)30434-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30434-5</ArticleId><ArticleId IdType="pmc">PMC7279758</ArticleId><ArticleId IdType="pubmed">32526193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. . Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med 2020; 383: 120-128. https://doi.org/10.1056/NEJMoa2015432 10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Menter T, Haslbauer JD, Nienhold R, et al. . Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 2020; 77: 198-209. https://doi.org/10.1111/his.14134 10.1111/his.14134</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14134</ArticleId><ArticleId IdType="pmc">PMC7496150</ArticleId><ArticleId IdType="pubmed">32364264</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Coppola S, Cressoni M, et al. . COVID-19 Does Not Lead to a &#x201c;Typical&#x201d; Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2020; 201: 1299-1300. https://doi.org/10.1164/rccm.202003-0817LE 10.1164/rccm.202003-0817LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0817LE</ArticleId><ArticleId IdType="pmc">PMC7233352</ArticleId><ArticleId IdType="pubmed">32228035</ArticleId></ArticleIdList></Reference><Reference><Citation>Maley JH, Winkler T, Hardin CC. Heterogeneity of Acute Respiratory Distress Syndrome in COVID-19: &#x201c;Typical&#x201d; or Not? Am J Respir Crit Care Med; 202: 618-619. https://doi.org/10.1164/rccm.202004-1106LE 10.1164/rccm.202004-1106LE</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1106LE</ArticleId><ArticleId IdType="pmc">PMC7427401</ArticleId><ArticleId IdType="pubmed">32579019</ArticleId></ArticleIdList></Reference><Reference><Citation>Doglioni C, Ravaglia C, Chilosi M, et al. . Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies. Respiration 2021; 100: 488-498. https://doi.org/10.1159/000514822 10.1159/000514822</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000514822</ArticleId><ArticleId IdType="pmc">PMC8018216</ArticleId><ArticleId IdType="pubmed">33725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilosi M, Poletti V, Ravaglia C, et al. . The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime. Mod Pathol 2021; 34: 1444-1455. https://doi.org/10.1038/s41379-021-00808-8 10.1038/s41379-021-00808-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-021-00808-8</ArticleId><ArticleId IdType="pmc">PMC8058579</ArticleId><ArticleId IdType="pubmed">33883694</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfefferkorn ER, Rebhun S, Eckel M. Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J Interferon Res 1986; 6: 267-279. https://doi.org/10.1089/jir.1986.6.267 10.1089/jir.1986.6.267</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.1986.6.267</ArticleId><ArticleId IdType="pubmed">2427623</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991; 5: 2516-2522</Citation><ArticleIdList><ArticleId IdType="pubmed">1907934</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung AW, Terentis AC, King NJ, et al. . Role of indoleamine 2,3-dioxygenase in health and disease. Clin Sci (Lond) 2015; 129: 601-672. https://doi.org/10.1042/CS20140392 10.1042/CS20140392</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20140392</ArticleId><ArticleId IdType="pubmed">26186743</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedlmayr P, Blaschitz A. Placental expression of indoleamine 2,3-dioxygenase. Wien Med Wochenschr 2012; 162: 214-219. https://doi.org/10.1007/s10354-012-0082-3 10.1007/s10354-012-0082-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10354-012-0082-3</ArticleId><ArticleId IdType="pubmed">22717876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu H, McKenzie G, et al. . Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010; 16: 279-285. https://doi.org/10.1038/nm.2092 10.1038/nm.2092</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2092</ArticleId><ArticleId IdType="pmc">PMC3556275</ArticleId><ArticleId IdType="pubmed">20190767</ArticleId></ArticleIdList></Reference><Reference><Citation>Zardoya-Laguardia P, Blaschitz A, Hirschmugl B, et al. . Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsia. Sci Rep 2018; 8: 5488. https://doi.org/10.1038/s41598-018-23896-0 10.1038/s41598-018-23896-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23896-0</ArticleId><ArticleId IdType="pmc">PMC5883010</ArticleId><ArticleId IdType="pubmed">29615752</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizawa H, Pryor-Koishi K, Kato T, et al. . Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007; 28: 487-497. https://doi.org/10.1016/j.placenta.2006.05.010 10.1016/j.placenta.2006.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2006.05.010</ArticleId><ArticleId IdType="pubmed">16860862</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizawa H, Ota S, Suzuki M, et al. . Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction. Reprod Biol Endocrinol 2011; 9: 107. https://doi.org/10.1186/1477-7827-9-107 10.1186/1477-7827-9-107</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7827-9-107</ArticleId><ArticleId IdType="pmc">PMC3199758</ArticleId><ArticleId IdType="pubmed">21810232</ArticleId></ArticleIdList></Reference><Reference><Citation>Santillan MK, Pelham CJ, Ketsawatsomkron P, et al. . Pregnant mice lacking indoleamine 2,3-dioxygenase exhibit preeclampsia phenotypes. Physiol Rep 2015; 3: e12257. https://doi.org/10.14814/phy2.12257 10.14814/phy2.12257</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.12257</ArticleId><ArticleId IdType="pmc">PMC4387753</ArticleId><ArticleId IdType="pubmed">25602015</ArticleId></ArticleIdList></Reference><Reference><Citation>Broekhuizen M, Hitzerd E, van den Bosch TPP, et al. . The Placental Innate Immune System Is Altered in Early-Onset Preeclampsia, but Not in Late-Onset Preeclampsia. Front Immunol 2021; 12: 780043. https://doi.org/10.3389/fimmu.2021.780043 10.3389/fimmu.2021.780043</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.780043</ArticleId><ArticleId IdType="pmc">PMC8724430</ArticleId><ArticleId IdType="pubmed">34992598</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts SW, Shaw S, Burnett R, et al. . Indoleamine 2,3-diooxygenase in periaortic fat: mechanisms of inhibition of contraction. Am J Physiol Heart Circ Physiol 2011; 301: H1236-47. https://doi.org/10.1152/ajpheart.00384.2011 10.1152/ajpheart.00384.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00384.2011</ArticleId><ArticleId IdType="pmc">PMC3197349</ArticleId><ArticleId IdType="pubmed">21841011</ArticleId></ArticleIdList></Reference><Reference><Citation>Struijk PC, Mathews VJ, Loupas T, et al. . Blood pressure estimation in the human fetal descending aorta. Ultrasound Obstet Gynecol 2008; 32: 673-681. https://doi.org/10.1002/uog.6137 10.1002/uog.6137</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/uog.6137</ArticleId><ArticleId IdType="pubmed">18816497</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ate I, van Baren N, Pilotte L, et al. . Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol Res 2015; 3: 161-172. https://doi.org/10.1158/2326-6066.CIR-14-0137 10.1158/2326-6066.CIR-14-0137</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2326-6066.CIR-14-0137</ArticleId><ArticleId IdType="pubmed">25271151</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Christou H, Liu L, et al. . Endothelial indoleamine 2,3-dioxygenase protects against development of pulmonary hypertension. Am J Respir Crit Care Med 2013; 188: 482-491. https://doi.org/10.1164/rccm.201304-0700OC 10.1164/rccm.201304-0700OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201304-0700OC</ArticleId><ArticleId IdType="pmc">PMC3778740</ArticleId><ArticleId IdType="pubmed">23822766</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Liu L, Visner GA. Nonviral gene delivery with indoleamine 2,3-dioxygenase targeting pulmonary endothelium protects against ischemia-reperfusion injury. Am J Transplant 2007; 7: 2291-300. https://doi.org/10.1111/j.1600-6143.2007.01942.x 10.1111/j.1600-6143.2007.01942.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2007.01942.x</ArticleId><ArticleId IdType="pubmed">17711549</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole JE, Astola N, Cribbs AP, et al. . Indoleamine 2,3-dioxygenase-1 is protective in atherosclerosis and its metabolites provide new opportunities for drug development. Proc Natl Acad Sci U S A 2015; 112: 13033-8. https://doi.org/10.1073/pnas.1517820112 10.1073/pnas.1517820112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1517820112</ArticleId><ArticleId IdType="pmc">PMC4620898</ArticleId><ArticleId IdType="pubmed">26438837</ArticleId></ArticleIdList></Reference><Reference><Citation>Forteza MJ, Polyzos KA, Baumgartner R, et al. . Activation of the Regulatory T-Cell/Indoleamine 2,3-Dioxygenase Axis Reduces Vascular Inflammation and Atherosclerosis in Hyperlipidemic Mice. Front Immunol 2018; 9: 950. https://doi.org/10.3389/fimmu.2018.00950 10.3389/fimmu.2018.00950</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00950</ArticleId><ArticleId IdType="pmc">PMC5949314</ArticleId><ArticleId IdType="pubmed">29867939</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolowczuk I, Hennart B, Leloire A, et al. . Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone. Am J Physiol Regul Integr Comp Physiol 2012; 303: R135-43. https://doi.org/10.1152/ajpregu.00373.2011 10.1152/ajpregu.00373.2011</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00373.2011</ArticleId><ArticleId IdType="pubmed">22592557</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SM, Park HY, Suh YS, et al. . Inhibition of acute lethal pulmonary inflammation by the IDO-AhR pathway. Proc Natl Acad Sci U S A 2017; 114: E5881-E5890. https://doi.org/10.1073/pnas.1615280114 10.1073/pnas.1615280114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1615280114</ArticleId><ArticleId IdType="pmc">PMC5530642</ArticleId><ArticleId IdType="pubmed">28673995</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans PC, Rainger GE, Mason JC, et al. . Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 2020; 116: 2177-2184. https://doi.org/10.1093/cvr/cvaa230 10.1093/cvr/cvaa230</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa230</ArticleId><ArticleId IdType="pmc">PMC7454368</ArticleId><ArticleId IdType="pubmed">32750108</ArticleId></ArticleIdList></Reference><Reference><Citation>Potus F, Mai V, Lebret M, et al. . Novel insights on the pulmonary vascular consequences of COVID-19. Am J Physiol Lung Cell Mol Physiol 2020; 319: L277-L288. https://doi.org/10.1152/ajplung.00195.2020 10.1152/ajplung.00195.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00195.2020</ArticleId><ArticleId IdType="pmc">PMC7414237</ArticleId><ArticleId IdType="pubmed">32551862</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, et al. . Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021; 21: 319-329. https://doi.org/10.1038/s41577-021-00536-9 10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia-Renteria H, Travieso A, Sagir A, et al. . In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int J Cardiol 2021; 345: 153-155. https://doi.org/10.1016/j.ijcard.2021.10.140 10.1016/j.ijcard.2021.10.140</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2021.10.140</ArticleId><ArticleId IdType="pmc">PMC8542397</ArticleId><ArticleId IdType="pubmed">34706286</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlo LMF, Pigott E, DuHadaway JB, et al. . IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis. J Immunol 2014; 192: 2082-2090. https://doi.org/10.4049/jimmunol.1303012 10.4049/jimmunol.1303012</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303012</ArticleId><ArticleId IdType="pmc">PMC3947779</ArticleId><ArticleId IdType="pubmed">24489090</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlo LM, Mandik-Nayak L. IDO2: A Pathogenic Mediator of Inflammatory Autoimmunity. Clin Med Insights Pathol 2016; 9: 21-28. https://doi.org/10.4137/CPath.S39930 10.4137/CPath.S39930</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/CPath.S39930</ArticleId><ArticleId IdType="pmc">PMC5119657</ArticleId><ArticleId IdType="pubmed">27891058</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatokun AA, Hunt NH, Ball HJ. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids 2013; 45: 1319-1329. https://doi.org/10.1007/s00726-013-1602-1 10.1007/s00726-013-1602-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-013-1602-1</ArticleId><ArticleId IdType="pubmed">24105077</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Schurink B, Roos E, et al. . Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19. J Pathol 2022; 256: 256-261. https://doi.org/10.1002/path.5842 10.1002/path.5842</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.5842</ArticleId><ArticleId IdType="pmc">PMC8897979</ArticleId><ArticleId IdType="pubmed">34859884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilosi M, Doglioni C, Ravaglia C, et al. . Unbalanced IDO1/IDO2 Endothelial Expression and Skewed Keynurenine Pathway in the Pathogenesis of COVID-19 and Post-COVID-19 Pneumonia. Biomedicines 2022; 10: 1332. https://doi.org/10.3390/biomedicines10061332 10.3390/biomedicines10061332</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10061332</ArticleId><ArticleId IdType="pmc">PMC9220124</ArticleId><ArticleId IdType="pubmed">35740354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Gomes MT, Mo Y, et al. . Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation. Int J Mol Sci 2023; 24: 7472. https://doi.org/10.3390/ijms24087472 10.3390/ijms24087472</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24087472</ArticleId><ArticleId IdType="pmc">PMC10138839</ArticleId><ArticleId IdType="pubmed">37108634</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, Huang XT, Li CH, et al. . CT features of coronavirus disease 2019 (COVID-19) with an emphasis on the vascular enlargement pattern. Eur J Radiol 2021; 134: 109442. https://doi.org/10.1016/j.ejrad.2020.109442 10.1016/j.ejrad.2020.109442</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109442</ArticleId><ArticleId IdType="pmc">PMC7694475</ArticleId><ArticleId IdType="pubmed">33321459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang M, Som A, Carey D, et al. . Pulmonary Vascular Manifestations of COVID-19 Pneumonia. Radiol Cardiothorac Imaging 2020; 2: e200277. https://doi.org/10.1148/ryct.2020200277 10.1148/ryct.2020200277</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/ryct.2020200277</ArticleId><ArticleId IdType="pmc">PMC7307217</ArticleId><ArticleId IdType="pubmed">34036264</ArticleId></ArticleIdList></Reference><Reference><Citation>Piciucchi S, Ravaglia C, Vizzuso A, et al. . Reversibility of venous dilatation and parenchymal changes density in Sars-Cov-2 pneumonia: toward the definition of a peculiar pattern. Pulmonology 2021; 27: 353-357. https://doi.org/10.1016/j.pulmoe.2020.10.010 10.1016/j.pulmoe.2020.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.010</ArticleId><ArticleId IdType="pmc">PMC7667388</ArticleId><ArticleId IdType="pubmed">33272912</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Chiumello D, Caironi P, et al. . COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020; 46: 1099-1102. https://doi.org/10.1007/s00134-020-06033-2 10.1007/s00134-020-06033-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06033-2</ArticleId><ArticleId IdType="pmc">PMC7154064</ArticleId><ArticleId IdType="pubmed">32291463</ArticleId></ArticleIdList></Reference><Reference><Citation>Busana M, Schiavone M, Lanfranchi A, et al. . Non-invasive hemodynamic profile of early COVID-19 infection. Physiol Rep 2020; 8: e14628. https://doi.org/10.14814/phy2.14628 10.14814/phy2.14628</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14628</ArticleId><ArticleId IdType="pmc">PMC7592880</ArticleId><ArticleId IdType="pubmed">33113285</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldani S, Ravaglia C, Bensai S, et al. . Pathophysiology of light phenotype SARS-CoV-2 interstitial pneumonia: from histopathological features to clinical presentations. Pulmonology 2022; 28: 333-344. https://doi.org/10.1016/j.pulmoe.2021.03.003 10.1016/j.pulmoe.2021.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2021.03.003</ArticleId><ArticleId IdType="pmc">PMC7997696</ArticleId><ArticleId IdType="pubmed">33832850</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu M, Guo X, et al. . Endogenous Retrovirus Elements Are Co-Expressed with IFN Stimulation Genes in the JAK-STAT Pathway. Viruses 2022; 15: 60. https://doi.org/10.3390/v15010060 10.3390/v15010060</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15010060</ArticleId><ArticleId IdType="pmc">PMC9861321</ArticleId><ArticleId IdType="pubmed">36680099</ArticleId></ArticleIdList></Reference><Reference><Citation>Blond JL, Bes&#xe8;me F, Duret L, et al. . Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 1999; 73: 1175-85. https://doi.org/10.1128/JVI.73.2.1175-1185.1999 10.1128/JVI.73.2.1175-1185.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.2.1175-1185.1999</ArticleId><ArticleId IdType="pmc">PMC103938</ArticleId><ArticleId IdType="pubmed">9882319</ArticleId></ArticleIdList></Reference><Reference><Citation>Holder BS, Tower CL, Abrahams VM, et al. . Syncytin 1 in the human placenta. Placenta 2012; 33: 460-466. https://doi.org/10.1016/j.placenta.2012.02.012 10.1016/j.placenta.2012.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2012.02.012</ArticleId><ArticleId IdType="pubmed">22381536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangeney M, Renard M, Schlecht-Louf G, et al. . Placental syncytins: Genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci U S A 2007; 104: 20534-9. https://doi.org/10.1073/pnas.0707873105 10.1073/pnas.0707873105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0707873105</ArticleId><ArticleId IdType="pmc">PMC2154466</ArticleId><ArticleId IdType="pubmed">18077339</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao S, Wang F, Chen H, et al. . Inducible knockout of Syncytin-A gene leads to an extensive placental vasculature deficiency, implications for preeclampsia. Clin Chim Acta 2017; 474: 137-146. https://doi.org/10.1016/j.cca.2017.09.012 10.1016/j.cca.2017.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2017.09.012</ArticleId><ArticleId IdType="pubmed">28935154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YN, Ye Y, Zhou D, et al. . The Role of Syncytin in Placental Angiogenesis and Fetal Growth. Front Cell Dev Biol 2022; 10: 852561. https://doi.org/10.3389/fcell.2022.852561 10.3389/fcell.2022.852561</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.852561</ArticleId><ArticleId IdType="pmc">PMC9039138</ArticleId><ArticleId IdType="pubmed">35493107</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M, Hu X, Pan Z, et al. . Endogenous retrovirus-derived enhancers confer the transcriptional regulation of human trophoblast syncytialization. Nucleic Acids Res 2023; 51: 4745-4759. https://doi.org/10.1093/nar/gkad109 10.1093/nar/gkad109</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkad109</ArticleId><ArticleId IdType="pmc">PMC10250217</ArticleId><ArticleId IdType="pubmed">36864754</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasent Blesa J, Candel V. Cell-cell fusion as a potential target in cancer therapy. Ecancermedicalscience 2009; 3: 145. https://doi.org/10.3332/ecancer.2009.145 10.3332/ecancer.2009.145</Citation><ArticleIdList><ArticleId IdType="doi">10.3332/ecancer.2009.145</ArticleId><ArticleId IdType="pmc">PMC3224012</ArticleId><ArticleId IdType="pubmed">22276010</ArticleId></ArticleIdList></Reference><Reference><Citation>Knerr I, Beinder E, Rascher W. Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol 2002; 186: 210-213. https://doi.org/10.1067/mob.2002.119636 10.1067/mob.2002.119636</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mob.2002.119636</ArticleId><ArticleId IdType="pubmed">11854637</ArticleId></ArticleIdList></Reference><Reference><Citation>Langbein M, Strick R, Strissel PL, et al. . Impaired cytotrophoblast cell-cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction. Mol Reprod Dev 2008; 75: 175-183. https://doi.org/10.1002/mrd.20729 10.1002/mrd.20729</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrd.20729</ArticleId><ArticleId IdType="pubmed">17546632</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruebner M, Strissel PL, Ekici AB, et al. . Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region. PLoS One 2013; 8: e56145. https://doi.org/10.1371/journal.pone.0056145 10.1371/journal.pone.0056145</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0056145</ArticleId><ArticleId IdType="pmc">PMC3573012</ArticleId><ArticleId IdType="pubmed">23457515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee X, Keith JC, Jr, Stumm N, et al. . Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 2001; 22: 808-812. https://doi.org/10.1053/plac.2001.0722 10.1053/plac.2001.0722</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/plac.2001.0722</ArticleId><ArticleId IdType="pubmed">11718567</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang XW, Li J, Brost BC, et al. . Decreased expression and altered methylation of syncytin-1 gene in human placentas associated with preeclampsia. Curr Pharm Des 2014; 20: 1796-1802. https://doi.org/10.2174/13816128113199990541 10.2174/13816128113199990541</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/13816128113199990541</ArticleId><ArticleId IdType="pubmed">23888950</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga L, Ali H, Secco I, et al. . Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia. Nature 2021; 594: 88-93. https://doi.org/10.1038/s41586-021-03491-6 10.1038/s41586-021-03491-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03491-6</ArticleId><ArticleId IdType="pmc">PMC7611055</ArticleId><ArticleId IdType="pubmed">33827113</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. . Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Netw Open 2021; 4: e210830. https://doi.org/10.1001/jamanetworkopen.2021.0830 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcis G, Bouquegneau A, Maes N, et al. . Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis 2021; 109: 209-216. https://doi.org/10.1016/j.ijid.2021.07.016 10.1016/j.ijid.2021.07.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.07.016</ArticleId><ArticleId IdType="pmc">PMC8278829</ArticleId><ArticleId IdType="pubmed">34273510</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021; 27: 601-615. https://doi.org/10.1038/s41591-021-01283-z 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur 2021; 6: 100122. https://doi.org/10.1016/j.lanepe.2021.100122 10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022; 22: e102-e107. https://doi.org/10.1016/S1473-3099(21)00703-9 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Z, Yang M, Lai CL. Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. Biomedicines 2021; 9: 966. https://doi.org/10.3390/biomedicines9080966 10.3390/biomedicines9080966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022; 23: 194-202. https://doi.org/10.1038/s41590-021-01104-y 10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou KM, Vasarmidi E, Russell AM, et al. . European Respiratory Society statement on long COVID follow-up. Eur Respir J 2022; 60: 2102174. https://doi.org/10.1183/13993003.02174-2021 10.1183/13993003.02174-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02174-2021</ArticleId><ArticleId IdType="pmc">PMC9349784</ArticleId><ArticleId IdType="pubmed">35144991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravaglia C, Doglioni C, Chilosi M, et al. . Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection. Eur Respir J 2022; 60: 2102411. https://doi.org/10.1183/13993003.02411-2021 10.1183/13993003.02411-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02411-2021</ArticleId><ArticleId IdType="pmc">PMC8932282</ArticleId><ArticleId IdType="pubmed">35301248</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovelace MD, Varney B, Sundaram G, et al. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 2017; 112 (Pt B): 373-388. https://doi.org/10.1016/j.neuropharm.2016.03.024 10.1016/j.neuropharm.2016.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.03.024</ArticleId><ArticleId IdType="pubmed">26995730</ArticleId></ArticleIdList></Reference><Reference><Citation>Braidy N, Grant R, Adams S, et al. . Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res 2009; 16: 77-86. https://doi.org/10.1007/s12640-009-9051-z 10.1007/s12640-009-9051-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-009-9051-z</ArticleId><ArticleId IdType="pubmed">19526301</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo-Huitr&#xf3;n R, Ugalde Mu&#xf1;iz P, Pineda B, et al. . Quinolinic acid: an endogenous neurotoxin with multiple targets. Oxid Med Cell Longev 2013; 2013: 104024. https://doi.org/10.1155/2013/104024 10.1155/2013/104024</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/104024</ArticleId><ArticleId IdType="pmc">PMC3780648</ArticleId><ArticleId IdType="pubmed">24089628</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietl M, Burkert F, Seiwald S, et al. . Interferon-gamma Mediated Metabolic Pathways in Hospitalized Patients During Acute and Reconvalescent COVID-19. Int J Tryptophan Res 2023; 16: 11786469231154244. https://doi.org/10.1177/11786469231154244 10.1177/11786469231154244</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/11786469231154244</ArticleId><ArticleId IdType="pmc">PMC10076985</ArticleId><ArticleId IdType="pubmed">37038445</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolou E, Rizwan M, Moustardas P, et al. . Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome. Front Immunol 2022; 13: 949787. https://doi.org/10.3389/fimmu.2022.949787 10.3389/fimmu.2022.949787</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.949787</ArticleId><ArticleId IdType="pmc">PMC9630598</ArticleId><ArticleId IdType="pubmed">36341457</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>